iSpecimen Inc.
For the period ended Dec 31, 2025. Filed Apr 1, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Apr 1, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. Form10-K Summary
None.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on April 1, 2026.
| iSPECIMEN, INC. | |
| By: | /s/ Katharyn Field |
| Katharyn Field | |
| Chief Executive Officer |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below on April 1, 2026, by the following persons on behalf of the registrant and in the capacities indicated:
| Signature | |
|---|---|
| /s/ Katharyn Field | Chief Executive Officer, Treasurer and Secretary |
| Katharyn Field | |
| /s/ Yuying Liang | Principal Accounting and Financial Officer |
| Yuying Liang | |
| /s/ Anthony Lau | Director |
| Anthony Lau | |
| /s/ Avtar Dhaliwal | Director |
| Avtar Dhaliwal | |
| /s/ Arphing (Tommy) Lee | Director |
| Arphing (Tommy) Lee | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.